Ware J. Anthony
SEC Form 4 insider trading activity
Ware J. Anthony has filed 3 SEC Form 4 filings (4 transaction rows) across 2 companies, including TRAX, ANAB, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Sep 4, 2026.
On the most recent filing, Ware J. Anthony is listed as Director at First Tracks Biotherapeutics, Inc. Inside the rolling window, Ware J. Anthony reported no open-market purchases and 2 open-market sales totaling $2.0M in TRAX and ANAB. The largest disclosed transaction in the window is a sale of 39,265 TRAX shares on Sep 2, 2026, worth $1.8M.
Companies traded
Other insiders at TRAX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.0M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Ware J. Anthony made?
Ware J. Anthony has filed 3 SEC Form 4 filings (4 transaction rows) across 2 companies, including TRAX, ANAB since 2025.
Which companies does Ware J. Anthony trade?
Ware J. Anthony has filed SEC Form 4 disclosures for 2 companies, including TRAX, ANAB.
When was Ware J. Anthony's most recent SEC Form 4 filing?
Ware J. Anthony's most recent SEC Form 4 filing on Tracefour is dated Sep 4, 2026.
What is Ware J. Anthony's total buy and sell value in the current window?
Inside the rolling retention window, Ware J. Anthony bought $0 and sold $2.0M based on SEC Form 4 filings.
What was Ware J. Anthony's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 39,265 TRAX shares on 2026-09-02, worth $1.8M, per SEC Form 4 filings.